IBRI Signs a License Agreement with Eli Lilly to Access its Fab Phage Display Library

IBRI Signs a License Agreement with Eli Lilly to Access its Fab Phage Display Library

Shots:

  • The Indiana Biosciences Research Institute collaborates with Lilly to identify new Ab & to validate new diagnostics by utilizing Lilly’s Fab Phage Display Library, advancing innovations from discovery to the clinic
  • The collaboration will speed up the discovery and validation of new antibodies and enhances IBRI’s capabilities to develop Ab targeting range of diseases
  • Lilly’s Phage Display Library is a cornerstone technology which serves a large database of known bacteriophages and contains the genetic information that encodes them and is used to discover & develop novel biotherapies

Click here to read full press release/ article | Ref: GlobeNewsWire | Image: OMC Technologies